HopeStage
Back to all studies
RecruitingNCT07046819

Tirzepatide in metabolic alcohol-related liver disease

About this titleRead the official source — NCT07046819
Medication studyAges 21–100United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 100 years.

What will I do during this study?

You receive a weekly injection under the skin of tirzepatide or saline for 12 weeks, depending on your assigned group. The study measures changes in body weight and liver fat from baseline to week 12.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 11, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
120
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 21 Years to 100 Years
Official registry ID
NCT07046819
Official title
Show the full official title

A Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Phase 2 Study of Efficacy and Safety of Tirzepatide in Individuals With Alcohol Use Disorder and Metabolic Alcohol-associated Liver Disease

Recruitment & locations

Currently recruiting

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.

Does this study involve medication?

Yes. The study involves medication, including Tirzepatide.

Who can participate?

Listed age limits: 21 years to 100 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies